Medicinova Stock Performance
as on November 10, 2026 at 6:33 am IST
Day's Low
$1.42$1.47
3.40%
Downside
52 Week's Low
52 Week's High
$1.22$3.90
17.01%
Downside
165.30%
Upside

Medicinova share price movements today
- Previous Close
- $1.46
- Open
- $1.44
- Volume
- 338.1K
- Market Cap
- $71.9M
- Day's Low - High
- $1.42 - $1.47
- 52 Week Low - High
- $1.22 - $3.90
Medicinova Historical Returns
- 1 Month Return
- -3.95 %
- 3 Month Return
- + 8.96 %
- 1 Year Return
- + 2.82 %
- 3 Year Return
- -18.44 %
- 5 Year Return
- -59.1 %
Medicinova Stock Fundamentals & Key Indicators
Check Medicinova market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$71.9M
EPS (TTM)
-0.2172
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-6.72
Industry PE ratio
-3.15
PEG Ratio
-0.77
EBITDA
-11.0M
Revenue (TTM)
920.5K
Profit Margin
42.39%
Return On Equity TTM
-26.51%
Medicinova vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Medicinova with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $71.9M | -59.10% | -6.72 | 42.39% | 0.00% | |
| Neutral | $101.5B | 7.32% | -35.95 | 28.00% | 0.00% | |
| StrongBuy | $46.5B | NA | 66.65 | 88.39% | 0.00% | |
| StrongBuy | $138.7B | 186.30% | 34.94 | 85.57% | 0.00% | |
| Buy | $93.5B | 46.74% | 19.26 | 85.77% | 0.41% |
Stock Returns calculator for Medicinova Stock including INR - Dollar returns
The Medicinova stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Medicinova investment value today
Current value as on today
₹1,09,613
Returns
₹9,613
(+9.61%)
Returns from Medicinova Stock
₹3,521 (+3.52%)
Dollar Impact
₹6,092 (+6.09%)
Analyst Recommendation on Medicinova Stock
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Medicinova. Average target price of $8.25
Medicinova Share Price Target
Get share price movements and forecasts by analysts on Medicinova.
What analysts predicted
82.18%UPSIDE
Target Price
$8.25
Current Price
$1.47
Analyzed by
7 Analysts
Target
$8.25
Medicinova target price $8.25, a slight upside of 82.18% compared to current price of $1.47. According to 7 analysts rating.
Indian Investors' Interest in Medicinova Stock
Search interest for Medicinova Stock has decreased by -91% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Medicinova Quarterly Profit & Loss
All numbers in Millions USD
Medicinova Annual Profit & Loss
All numbers in Millions USD
Medicinova Quarterly Cash Flow
All numbers in Millions USD
Medicinova Annual Cash Flow
All numbers in Millions USD
Medicinova News & Key Events

Today's Timeline - 28 September
Mon, 03:45 PM
-MediciNova reports positive topline results from Phase 2 trial of MN-001 for treating hypertriglyceridemia and liver disease.
Tue, 02:42 AM
-MediciNova extends office lease to April 2030, indicating long-term stability and commitment to current operations.
Insights on Medicinova
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise

In the last 3 months, MNOV stock has moved up by 9.0%
NO EFFECTAgainst Peers

In the last 1 year, Moderna, Inc. Common Stock has given 935.8% return, outperforming this stock by 933.0%
NO EFFECTAgainst Peers

In the last 3 years, Moderna, Inc. Common Stock has given 265.7% return, outperforming this stock by 284.1%
About Medicinova
| Organisation | Medicinova |
| Headquarters | 4275 Executive Square, La Jolla, CA, 92037, US |
| Industry | Biotechnology |
| CEO | Yuichi Iwaki |
Key Management of Medicinova
Name | Title |
|---|---|
Dr. Yuichi Iwaki M.D., Ph.D. | Co-Founder, President, CEO & Chairman |
Dr. Kazuko Matsuda M.D., M.P.H., Ph.D. | Senior VP, Chief Medical Officer & Director |
Dr. David H. Crean M.B.A., Ph.D. | Chief Business Officer |
Mr. Jason J. Kruger CPA | CFO & Principal Financial Officer |
FAQs
What is Medicinova share price today?
Medicinova share price today is $1.47 as on . Medicinova share today touched a day high of $1.47 and a low of $1.42.
What is the 52 week high and 52 week low for Medicinova share?
Medicinova share touched a 52 week high of $3.90 on and a 52 week low of $1.22 on . Medicinova stock price today i.e. is trending at $1.47,which is 62.31% down from its 52 week high and 20.49% up from its 52 week low.
What is Medicinova's market capitalisation today?
Medicinova market capitalisation is $0.00T as on .
How to invest in Medicinova Stock (MNOV) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Medicinova on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Medicinova Stock (MNOV) from India?
Indian investors can start investing in Medicinova (MNOV) shares with as little as ₹93.92749786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.27 in Medicinova stock (as per the Rupee-Dollar exchange rate as on ).
Based on Medicinova share’s latest price of $1.47 as on November 10, 2026 at 1:03 am IST, you will get 6.8027 shares of Medicinova. Learn more about
fractional shares .
What are the returns that Medicinova has given to Indian investors in the last 5 years?
Medicinova stock has given -59.1% share price returns and 26.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?